<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>N-<z:chebi fb="0" ids="30353">isopropyl</z:chebi>-p[123I]iodoamphetamine (123I-<z:chebi fb="54" ids="17202">IMP</z:chebi>) SPECT and quantitative regional cerebral blood flow (rCBF) studies were performed in 111 patients with <z:e sem="disease" ids="C0234387" disease_type="Disease or Syndrome" abbrv="">cerebral disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Continuous arterial blood sampling method based on the microsphere model was used as a quantitative rCBF measurement </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated rCBF in patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and also in patients with poor activities of daily living (ADL) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> showed significant reduction of mean CBF in contrast to patients without <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Significant decrease of rCBF in the bilateral frontal cortex, parietal cortex and basal ganglia and the right temporal cortex were found in <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>Although patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> showed decreased rCBF in bilateral basal ganglia, <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients with <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> showed no significant reduction of rCBF in any regions </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with poor ADL showed decreased rCBF in <z:hpo ids='HP_0000001'>all</z:hpo> brain regions </plain></SENT>
<SENT sid="7" pm="."><plain>And particularly frontal and basal ganglionic defects were most pronounced </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with poor ADL resulted from <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> showed significant decrease of rCBF in bilateral basal ganglia </plain></SENT>
<SENT sid="9" pm="."><plain>However, there was no significant correlation in <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> between ADL and rCBF </plain></SENT>
<SENT sid="10" pm="."><plain>The rCBF measurement with 123I-<z:chebi fb="54" ids="17202">IMP</z:chebi> is useful for clinical evaluation of <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients and patients with poor ADL </plain></SENT>
</text></document>